Aurobindo Pharma attends BofA 2026 India Conference on June 2
Aurobindo Pharma Limited announced its participation in the BofA 2026 India Conference scheduled for June 2, 2026, in Mumbai. Company officials will conduct in-person and group meetings between 09:00 AM and 06:00 PM IST. The company confirmed that no unpublished price sensitive information will be disclosed during these interactions.
*this image is generated using AI for illustrative purposes only.
Aurobindo Pharma Limited will participate in the BofA 2026 India Conference on June 2, 2026, in Mumbai. The company's officials will engage in in-person and group meetings during the event. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
The meeting is scheduled to take place from 09:00 AM to 06:00 PM (IST). The schedule is subject to change due to exigencies on the part of the investor or the company. The disclosure was made to the National Stock Exchange of India Limited and BSE Limited under Regulation 30.
Meeting Details
| Date | Time | Investor/Meeting name | Type of meeting | Location |
|---|---|---|---|---|
| June 2, 2026 | 09:00 AM to 06:00 PM (IST) | BofA 2026 India Conference | In-person and group meetings | Mumbai |
Historical Stock Returns for Aurobindo Pharma
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.75% | +2.30% | -0.18% | +23.86% | +35.51% | +57.26% |
What strategic priorities is Aurobindo Pharma likely to emphasize during the BofA 2026 India Conference?
How might investor sentiment shift following Aurobindo Pharma's engagement at the conference?
What potential market impacts could arise from the discussions, despite no UPSI being shared?
18
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
